Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes

American Journal of Cardiology

Volumn 86, Issue 7, 2000, Pages 713-717

  Januzzi, James L ^a   Hahn, Samuel S ^a   Chae, Claudia U ^a   Giugliano, Robert ^a   Lewandrowski, Kent ^a   Theroux, Pierre ^b   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PLACEBO; TIROFIBAN; TROPONIN I;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANGINA, UNSTABLE; ANTICOAGULANTS; CORONARY DISEASE; CREATINE KINASE; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE, CONGESTIVE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REGRESSION ANALYSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TROPONIN I; TYROSINE;

EID: 0034307089     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01068-7     Document Type: Article

References (22)

1. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE Study . Lancet. 349:1997;1429-1435.
2. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet glycoprotein IIb/IIIa in unstable angina receptor supression using integrelin therapy. The PURSUIT Trial . N Engl J Med. 339:1998;436-443.
3. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Trial. N Engl J Med. 338:1998;1498-1505.
4. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial. N Engl J Med. 338:1998;1488-1497.
5. Huntsberger D.V., Billingsley P. Elements of Statistical Inference. 1973;Allyn and Bacon, Boston, MA.
6. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljungdahl L., Goldmann B., Katus H.A. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
7. Ravkilde J., Nissen H., Horder M., Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chains levels in suspected acute myocardial infarction analysis of 28 months of followup in 196 patients . J Am Coll Cardiol. 25:1995;574-581.
8. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657.
9. Hamm C.W., Goldman B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 337:1997;1648-1653.
10. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., Fischer G.A., Fung A.Y., Thompson C., Wybenga D., Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
11. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell F.E., Califf R.M., Topol E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
12. Galvani M., Ottani F., Ferrini D., Ladenson J.H., Destro A., Baccos D., Rusticali F., Jaffe A.S. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 95:1997;2053-2059.
13. Benamer H., Steg P.G., Benessiano J., Vicaut E., Gaultier C.J., Aubry P., Boudvillain O., Sarfati L., Brochet E., Feldman L.J., Juliard J.M., Assayag P. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 137:1999;815-820.
14. Hamm C.W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C.M., Rutsch W., Berger J., Kootstra J., Simoons M.L. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 340:1999;1623-1629.
15. Davies M.J., Thomas A.C., Knapman P.A., Hangartner J.R. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 73:1986;418-427.
16. Falk E. Unstable angina with fatal outcome dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion . Circulation. 71:1985;699-708.
17. Farb A., Burke A.P., Tang Al. , Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden cardiac death. Circulation. 93:1996;1354-1363.
18. Theroux P., Fuster V. Acute coronary sydromes unstable angina and non-Q-wave myocardial infarction . Circulation. 97:1998;1195-1206.
19. Davies M.J. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation. 82:(suppl II):1990;II-38-II-46.
20. Neumann F.J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gawaz M., Kastrati A., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction. Circulation. 98:1998;2695-2701.
21. Omura T., Teragaki M., Tani T., Yamagishi H., Yanagi S., Nishikimi T., Yoshiyama M., Toda I., Akioka K., Takeuchi K. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J. 57:1992;1062-1070.
22. Alexander J.H., Sparapani R.A., Mahaffey K.W., Boersma E., Lincoff A., Wilcox R.G., Michael M.M., Simoons M.L., Topol E.J., Califf R.M., Harrington R.A. Eptifibatide reduces the size and incidence of myocardial infarction in patients with non-ST elevation acute coronary syndromes (abstr). J Am Coll Cardiol. 33:1999;331A.